Clinical implications of the specialised B cell response to polysaccharide encapsulated pathogens

Postgraduate Medical Journal

Volumn 77, Issue 911, 2001, Pages 562-569

  Vinuesa, C G ^a   De Lucas, C ^b   Cook, M C ^c  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b HOSPITAL SAN RAFAEL   (Spain)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; COMPLEMENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN SUBCLASS;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; B LYMPHOCYTE ACTIVATION; BACTERIAL MEMBRANE; COMPLEMENT ACTIVATION; GENE REARRANGEMENT; HUMAN; IMMUNOREACTIVITY; INFECTION RESISTANCE; LYMPH NODE; MEMORY CELL; OPSONIZATION; REVIEW; SPLEEN;

B-LYMPHOCYTES; BACTERIAL CAPSULES; BACTERIAL INFECTIONS; DISEASE SUSCEPTIBILITY; HAEMOPHILUS INFECTIONS; HUMANS; IMMUNE TOLERANCE; MENINGOCOCCAL INFECTIONS; PNEUMOCOCCAL INFECTIONS;

EID: 0034840031     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.77.911.562     Document Type: Review

References (56)

1. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study
2. Molecular and cellular biology of pneumococcal infection
3. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis
4. H genes occurs in the newly generated repertoire of neonatal and adult mice
5. Immaturity of the human splenic marginal zone in infancy - Possible contribution to the deficient infant immune response
6. Hazards of hyposplenism
7. Impaired human antibody response to the thymus independent antigen, DNP-Ficoll, after splenectomy. Implications for post-splenectomy infections
8. Postsplenectomy sepsis and its mortality rate: Actual versus perceived risks
9. Infection associated with asplenia: Risks, mechanisms, and prevention
10. Complement deficient states and infection: Epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency
11. Recurrent systemic bacterial infections in C2 deficiency
12. Complement analysis in adult patients with a history of bacteremic pneumococcal infections or recurrent pneumonia
13. C4B deficiency: A risk factor for bacteremia with encapsulated organisms
14. Complement factor I deficiency in a family with recurrent infections
15. Persistently circulating C3 nephritic factor (C3 NeF)-stabilized alternative pathway C3 convertase (C3 CoF) in serum of an 11-year-old gift with meningococcal septicemia - Simultaneous occurrence with free C3 NeF
16. Recurrent meningococcal septicaemia and properdin deficiency
17. Association of variants of the gene for mannose binding lectin with susceptibility to meningococcal disease
18. Neisseria meningitidis and Neisseria gonorrhoea bacteremia associated with C6, C7, or C8 deficiency
19. Meningococcal disease in patients with late complement component deficiency: Studies in the USSR
20. T cell-independent antigens type 2
21. T-independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci
22. Germinal centres without T cells
23. CBA/N immune defective mice: Evidence for the failure of a B cell subpopulation to be expressed
24. Colocalization of X-linked agammaglobulinaemia and X-linked immunodeficiency genes
25. Functional analysis of peripheral blood B cells in patients with X-linked agammaglobulinemia
26. The role of B cells in acute and chronic infections
27. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients
28. Encephalomyelitis in primary hypogammaglobulinaemia
29. Recent progress in the diagnosis and treatment of patients with defects in early B-cell development
30. An essential role for BLNK in human B cell development
31. Xid-like phenotypes: A B cell signallosome takes shape
32. Marginal zone macrophages and their role in the immune response against T-independent type 2 antigens: Modulation of the cells with specific antibody
33. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response
34. Differences in the recruitment of virgin B cells into antibody responses to thymus dependent and thymus independent type-2 antigens
35. Marginal zone of the spleen and the development and localisation of specific antibody-forming cells against thymus-independent type-2 antigens
36. Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activity
37. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM
38. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response
39. The effects of subclass on the ability of anti-phosphocholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae
40. Inherited deletion of immunoglobulin heavy chain constant region genes in normal human individuals
41. Activation of the alternative complement pathway by Haemophilus influenzae, type b
42. Antibody response to meningococcal polysaccharides A and C in patients with complement defects
43. IgG subclasses in selective IgA deficiency: Importance of IgG2-IgA deficiency
44. Selective gamma-globulin deficiencies in patients with recurrent pyogenic infections
45. Prevalence of congenital or acquired complement deficiency in patients with sporadic meningocococcal disease
46. Familial properdin deficiency and fatal meningococcemia: Correction of the bactericidal defect by vaccination
47. Hox11 controls the genesis of the spleen
48. Implications of agenesis of the spleen on the pathogenesis on conotruncus anomalies in childhood
49. Efficacy of pneumococcal vaccination in adults: A meta-analysis of randomized controlled trials
50. 23-Valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: Double-blind, randomised and placebo controlled trial
51. Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood
52. Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the non-toxic protein CRM197
53. Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme
54. Epidemiology of pneumococcal serotypes and conjugate vaccine formulations
55. Enhancement of T cell-independent immune responses in vivo by CD40 antibodies
56. Anti-CD40 antibody enhances responses to polysaccharide without mimicking T cell help